Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 14, 2009

TAP and Cellectricon to Offer High-Throughput Patch-Clamp Equipment

  • The Advanced Projects Group of The Automation Partnership (TAP) is collaborating with Cellectricon to produce fully automated, high-throughput patch-clamp equipment known as the Dynaflow®HT System. 

    Patch clamping is used for screening ion channels in drug discovery. The Dynaflow®HT System, which has been developed in collaboration with AstraZeneca in Sweden, is now becoming commercially available and addresses the limits of existing ion-channel screening equipment by combining high levels of automated throughput with accurate and affordable data measurement. 



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »